Show the full website
Medicin & Biotek
Medico & Rehab
Laboratorie & Diagnostik
Sygdom & Sundhed
Top picks in English
WS Audiology puts 700 employees on paid leave
Lundbeck research director after double fiasco: We have much more interesting assets to work on
Zealand Pharma applies for FDA approval for blood sugar treatment
Xellia lands record profit of DKK 440 million (USD 64.5 million) - revenue increases by 15 percent.
Supplier to hearing aid industry lands double-digit growth after first year under new owners
Leo Foundation sees purchasing opportunities in corona crisis
Genmab continues with partner hunt for billion-dollar candidate despite corona obstacles
Bavarian misses share issue target but is still satisfied: "We have experienced huge support from our shareholders"
Azanta chairman after sale to billion-kroner Dutch group: "We have got our happy ending"
Biotech profile becomes new Inprother CEO
Zealand chief medical officer on abandoned Boehringer collaboration: "We need to look at the data"
Danish hospital to test malaria medicine against coronavirus
European medtech industry appeals to EU commission: Delay new rules
Orifarm has high hopes for new business arm - may be the key to the US market
Cochlear terminates contract with Danish service provider
Novo Holdings eyes opportunities in equity downturn: "We also invested when people fled in 2008"
FDA opens doors to biosimilar, interchangable insulin products - analysts doubt impact
Novo Nordisk CSO puts faith in new drug in fight for hemophilia market
Oncology Venture after meeting with FDA about cancer drug: "We are close - but not quite over the finish line"
Novo CSO on hemophilia drug's chances: "It doesn't look great"
Head of Phase I Unit at Rigshospitalet: A matter of time before we stop recruiting for clinical trials
Coronavirus affects clinical trials – Medicines Agency expects problems
Investors opposed Visiopharm's plan for an initial public offering in Sweden - now the company is considering becoming listed in Denmark
Zealand boss ahead of first FDA application: "We are already looking at the next challenges"
EU commission chair speaks personally to vaccine company